BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

399 related articles for article (PubMed ID: 15523891)

  • 1. Cutaneus pseudolymphoma: a case report.
    Dragonetti E; Cianchini G; Mastrangelo L; Mellone P; Baldi A
    In Vivo; 2004; 18(5):549-51. PubMed ID: 15523891
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pseudolymphoma and cutaneous lymphoma: facts and controversies.
    Bergman R
    Clin Dermatol; 2010; 28(5):568-74. PubMed ID: 20797521
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Borrelia-associated lymphocytoma cutis].
    Palmen C; Jamblin P; Florkin B; Hoyoux C
    Arch Pediatr; 2010 Aug; 17(8):1159-61. PubMed ID: 20573489
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differential diagnosis between cutaneous lymphoma and pseudolymphoma.
    Cerroni L; Goteri G
    Anal Quant Cytol Histol; 2003 Aug; 25(4):191-8. PubMed ID: 12961825
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A nodular syphilid presenting as a pseudolymphoma: mimicking a cutaneous marginal zone B-cell lymphoma.
    Moon HS; Park K; Lee JH; Son SJ
    Am J Dermatopathol; 2009 Dec; 31(8):846-8. PubMed ID: 19786852
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pseudolymphoma evolving into diffuse large B-cell lymphoma.
    Anandasabapathy N; Pulitzer M; Epstein W; Rosenman K; Latkowski JA
    Dermatol Online J; 2008 May; 14(5):22. PubMed ID: 18627758
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Primary cutaneous lymphoproliferative disorders with dual lineage rearrangement.
    Kazakov DV; Kutzner H; Palmedo G; Boudova L; Michaelis S; Michal M; Vanecek T; Magro CM; Mukensnabl P; Dummer R; Burg G; Kempf W
    Am J Dermatopathol; 2006 Oct; 28(5):399-409. PubMed ID: 17012914
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Childhood cutaneous lymphoid hyperplasia following feline scratches.
    Madhogaria S; Carr RA; Gach JE
    Pediatr Dermatol; 2010; 27(3):294-7. PubMed ID: 20609149
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Diagnosis and classification of cutaneous pseudolymphoma. Historical review and perspectives].
    Rijlaarsdam JU; Willemze R
    Ann Dermatol Venereol; 1993; 120(1):100-6. PubMed ID: 8338321
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Primary cutaneous marginal zone B-cell lymphoma: clinical and histological aspects.
    Khaled A; Sassi S; Fazaa B; Ben Hassouna J; Ben Romdhane K; Kamoun MR
    Pathologica; 2009 Feb; 101(1):18-20. PubMed ID: 19771768
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Item 164--Malignant lymphomas: cutaneous lymphomas].
    CEDEF
    Ann Dermatol Venereol; 2012 Oct; 139(11 Suppl):A164-6. PubMed ID: 23176840
    [No Abstract]   [Full Text] [Related]  

  • 12. Cutaneous pseudolymphoma induced by Hirudo medicinalis therapy.
    Choi Y; Kim SC
    J Dermatol; 2012 Feb; 39(2):195-7. PubMed ID: 22142279
    [No Abstract]   [Full Text] [Related]  

  • 13. [Cutaneous lymphoid hyperplasia (pseudolymphoma) on the red dye of a tattoo].
    Gardair Bouchy C; Kerdraon R; Kluger N; Armingaud P; Wakosa A; Estève E
    Ann Pathol; 2013 Aug; 33(4):273-7. PubMed ID: 23954123
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A case of multiple nodular cutaneous B-cell pseudolymphoma successfully treated with glucocorticoid, methotrexate, and hydroxychloroquine.
    Han B; Liu H; Wang H
    Dermatol Ther; 2022 Nov; 35(11):e15812. PubMed ID: 36088631
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Cutaneous pseudolymphoma caused by carbamazepine].
    d'Incan M; Mouillet ML; Roger H; Ferrier MC; Buono JP; Déchelotte P; Bignon YJ; Souteyrand P
    Ann Dermatol Venereol; 1998 Jan; 125(1):52-5. PubMed ID: 9747211
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-related CD8+ cutaneous pseudolymphoma: efficacy of methotrexate.
    Ingen-Housz-Oro S; Sbidian E; Ortonne N; Penso-Assathiany D; Chambrin V; Bagot M; Bachelez H; Wolkenstein P; Chosidow O
    Dermatology; 2013; 226(1):15-8. PubMed ID: 23343593
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hyperplasia of hair follicles and other adnexal structures in cutaneous lymphoproliferative disorders: a study of 53 cases, including so-called pseudolymphomatous folliculitis and overt lymphomas.
    Kazakov DV; Belousova IE; Kacerovska D; Sima R; Vanecek T; Vazmitel M; Pizinger K; Michal M
    Am J Surg Pathol; 2008 Oct; 32(10):1468-78. PubMed ID: 18685486
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Idiopathic Cutaneous Pseudolymphoma Treated Successfully with Hydroxychloroquine: A Case Report and Literature Review.
    Mizuno H; Takahagi S; Morita S; Kamegashira A; Tanaka A
    Acta Derm Venereol; 2022 Oct; 102():adv00798. PubMed ID: 36250760
    [No Abstract]   [Full Text] [Related]  

  • 19. Reduced number of CD1a+ cells in cutaneous B-cell lymphoma.
    Schmuth M; Sidoroff A; Danner B; Topar G; Sepp NT
    Am J Clin Pathol; 2001 Jul; 116(1):72-8. PubMed ID: 11447755
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic Challenges and Treatment Options for Cutaneous T Cell Pseudolymphoma: A Case Study with Rituximab Treatment.
    Balode D; Beļajeva L; Ruesseler V; Quaas A; Lejniece S
    Am J Case Rep; 2020 Jan; 21():e919616. PubMed ID: 31919337
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.